Pancreatic and Hepatic Oncology Research
Pancreatic and Hepatic Oncology Research is a research topic within Oncology. Science Explorer counts 69k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the research and treatment of pancreatic cancer, covering topics such as surgical complications, chemotherapy regimens (e.g., Gemcitabine), tumor microenvironment, genomic analyses, stromal biology, neoadjuvant therapy, and immunotherapy. The papers also discuss the impact of hospital volume on surgical outcomes and the prevalence of pancreatic cysts.
- Pancreatic Cancer
- Surgical Complications
- Gemcitabine
- Tumor Microenvironment
- Genomic Analyses
- Chemotherapy
- Stromal Biology
- Neoadjuvant Therapy
- Metastatic Pancreatic Cancer
- Immunotherapy
- Research works
- 69k fractional, since 1950
- In the world top 10%
- 7k per year above
- Top-10% rate
- 10.1% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +8% the tick is no change
- Largest producer
United States
30% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Pancreatic and Hepatic Oncology Research research?
By volume, the United States and China publish the most (4k and 3.2k works in 2022-now).
By volume, 2022-now
- 1
United States 4k works
- 2
China 3.2k works
- 3
Japan 1.7k works
- 4
Italy 814 works
- 5
India 705 works
- 6
Germany 661 works
- 7
United Kingdom 636 works
- 8
South Korea 551 works
- 9
Spain 469 works
- 10
France 410 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Pancreatic and Hepatic Oncology Research research?
By volume in 2022-now, Harvard University publishes the most Pancreatic and Hepatic Oncology Research research, followed by Mayo Clinic and The University of Texas MD Anderson Cancer Center.
By volume, 2022-now
- 1
Harvard University
United States 157 works
- 2
Mayo Clinic
United States 128 works
- 3
The University of Texas MD Anderson Cancer Center
United States 127 works
- 4
Sun Yat-sen University
China 118 works
- 5
Sichuan University
China 107 works
- 6
Shanghai Jiao Tong University
China 103 works
- 7
Johns Hopkins University
United States 99 works
- 8
The Ohio State University
United States 98 works
- 9
Chinese Academy of Medical Sciences & Peking Union Medical College
China 96 works
- 10
Zhejiang University
China 90 works
Who are the leading researchers in Pancreatic and Hepatic Oncology Research?
The most-cited researchers publishing on Pancreatic and Hepatic Oncology Research include Douglas G. Altman, Ahmedin Jemal and Freddie Bray.
- 1
Douglas G. Altman
United Kingdom 862k citations
- 2
Ahmedin Jemal
United States 761k citations
- 3
Freddie Bray
France 550k citations
- 4
Eric S. Lander
United States 524k citations
- 5
Jacques Ferlay
France 486k citations
- 6
George Davey Smith
United Kingdom 435k citations
- 7
Ali H. Mokdad
United States 429k citations
- 8
Walter Churchill Willett
United States 411k citations
- 9
Stacey L. Gabriel
United States 402k citations
- 10
Peer Bork
Germany 396k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Pancreatic and Hepatic Oncology Research research done?
The largest centres of Pancreatic and Hepatic Oncology Research research in 2022-now are Beijing (China), Shanghai (China), Tokyo (Japan) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Rozzano, Verona and Wakayama.
Largest cities, 2022-now
- 1
Beijing
China 408 works
- 2
Shanghai
China 375 works
- 3
Tokyo
Japan 359 works
- 4
Seoul
South Korea 310 works
- 5
New York
United States 233 works
- 6
Guangzhou
China 203 works
- 7
Houston
United States 182 works
- 8
Hangzhou
China 171 works
- 9
Nanjing
China 159 works
- 10
London
United Kingdom 158 works
Where it is the local speciality
- RozzanoIT · 46.1 works18×
- VeronaIT · 75.3 works18×
- WakayamaJP · 26.3 works17×
Location quotient: how much more of its research is in Pancreatic and Hepatic Oncology Research than the world average.
Where is the best place to study Pancreatic and Hepatic Oncology Research?
Among universities, judged by research, Johns Hopkins University, Harvard University and Sun Yat-sen University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Pancreatic and Hepatic Oncology Research, country by countryIs Pancreatic and Hepatic Oncology Research research growing?
Output in 2022-2025 was 8% higher than in 2018-2021, peaking in 2024. The fastest-growing topics are Pancreatic and Hepatic Oncology Research.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Pancreatic and Hepatic Oncology Research as a percentage of every work published that year, 0.073% in 2024.
Fractional works of Pancreatic and Hepatic Oncology Research over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Questions people ask
Which institutions lead pancreatic cancer research?
By volume in 2022-now, Harvard University publishes the most Pancreatic and Hepatic Oncology Research research, followed by Mayo Clinic and The University of Texas MD Anderson Cancer Center.
Which institutions lead Pancreatic and Hepatic Oncology Research research?Discussion
Ask a question or share a note about Pancreatic and Hepatic Oncology Research. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.